GlassScriptPhysician profile
Thomas D Person
NPI 1811154867
$9,680.66
in general payments reported to CMS, 2019-2025
25 companies · $2,368 in 2025
The $2,368 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $386 · 2020: $83.35 · 2021: $211 · 2022: $527 · 2023: $1,225 · 2024: $4,880 · 2025: $2,368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,870 · Travel and Lodging: $2,102 · Education: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,870.27 |
| Travel and Lodging | $2,102.41 |
| Education | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,924.06 | 2024-2025 | |
| Edwards Lifesciences Corporation | $3,577.79 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $380.33 | 2019-2025 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $322.53 | 2022-2025 | Corevalve Evolut R, Venaseal |
| Atricure, INC. | $300.02 | 2019-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Smith+Nephew, INC. | $198.82 | 2023-2025 | Stravix Mesh, Stravix, Oasis Micro |
| Abiomed | $187.64 | 2019-2025 | Impella |
| Livanova USA, INC. | $135.33 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $91.93 | 2022-2023 | Sternalock Blu System |
| Getinge USA Sales, LLC | $91.46 | 2020-2025 | Vasoview Hemopro 2 |
| Medtronic Vascular, INC. | $73.90 | 2019 | |
| Terumo Cardiovascular Systems Corporation | $68.54 | 2020-2024 | Virtuosaph Plus With Radial Indication, Capiox Fx Advance Hollow Fiber Oxygenator W Integrated Af W Hardshell Res. |
| Davol INC. | $54.02 | 2021-2023 | |
| Innovation Technologies INC | $42.50 | 2023 | Irrisept |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $32.03 | 2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $30.43 | 2023 | Kcentra |
| Ethicon US, LLC | $23.26 | 2023 | Prolene |
| Cook Medical LLC | $21.65 | 2024 | Zilver Ptx |
| Artivion, INC. | $21.40 | 2019 | |
| Angiodynamics, INC. | $20.88 | 2025 | Angiovac |
| E.R. Squibb & Sons, L.L.C. | $20.83 | 2024 | Camzyos |
| Lsi Solutions INC | $20.20 | 2024 | Cor-Knot |
| Teva Pharmaceuticals USA, INC. | $15.16 | 2025 | Uzedy |
| Lemaitre Vascular, INC. | $13.94 | 2023 | Hydro Lemaitre Valvulotome |
| Avanos Medical | $12.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Person listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.